alexa <p>"Obesity paradox" and Cardiovascular Disease: Myth or a Better Clinical Outcome?</p> | OMICS International "> "> "/>
ISSN: 2471-9919
Evidence based Medicine and Practice
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

"Obesity paradox" and Cardiovascular Disease: Myth or a Better Clinical Outcome?

Leonardo Roever1* and Chagas ACP2,3

1Department of Clinical Research, Federal University of Uberlândia, Uberlândia, Brazil

2Heart Institute (InCor), HCFMUSP-University of São Paulo Medical School, São Paulo, Brazil

3Faculty of Medicine ABC, Santo André, Brazil

Corresponding Author:
Leonardo Roever
Department of Clinical Research
Av Pará, 1720 - Bairro Umuarama
Uberlândia-MG-CEP 38400-902, Brazil
Tel: +553488039878
E-mail: [email protected]

Received date: November 19, 2015; Accepted date: November 26, 2015; Published date: December 03, 2015

Citation: Roever L,ACP C(2016) "Obesity paradox" and Cardiovascular Disease: Myth or a Better Clinical Outcome? . Evidence Based Medicine and Practice 1:e102. doi: 10.4172/2471-9919.1000e102

Copyright: © 2015 Roever L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Evidence based Medicine and Practice


Obesity is linked to traditional cardiovascular risk factors like, metabolic syndrome, hypertension, hyperlipidemia and diabetes, dyslipidemia, diabetes mellitus, sleep apnoea syndrome, reduced insulin sensitivity, enhanced free fatty acid turnover, increased basal sympathetic tone, a hypercoagulable state, systemic inflammation and suspected to incur increased morbidity and mortality [1-6].

Body Mass Index (BMI) is a patient's weight in kilograms divided by the square of height in meters. BMI to define underweight, normal weight, overweight, and various classes of obesity (Table 1) [7-10].

Classification  BMI Risk of Developing Health Problems
Underweight 18.5 Increased
Ideal BMI 18.5–24.9 Least
Overweight 25-30 Increased
Obese I 30.0–34.9 High
Obese II 35.0–39.9 Very high
Obese III >40 Extremely high
Super Obese >50 Super high

Table 1: BMI classification.

Hansel and colleagues report a study to explore the relation between BMI and cardiovascular (CV) disease, and the influence of optimal medical therapy (OMT) on this relationship. Patients from the REACH cohort with or at high risk of atherosclerosis, were followed up to 4 years (n=54 285). Patients were categorized according to baseline BMI (underweight to Grade III obesity). OMT was defined as the use of the four cardioprotective medication classes (statins, ACE inhibitors/ angiotensin II receptor blockers, β-blockers, and antiplatelet agents). The main outcomes were all-cause mortality, CV mortality, and CV events. In primary and secondary prevention, a reverse J-shaped curve best described the relationship between BMI categories and the incidence of the various outcomes. In secondary prevention, the highest adjusted risks were observed for underweight patients (1.97, P<0.01, and 1.29, P=0.03, for CV mortality and CV events) and the lowest HRs were observed, respectively, in Grade II and Grade III obese patients (0.73, P<0.01 and 0.80, P<0.01). The patients on OMT increased with BMI from 10.1 to 36% (P<0.001) [11].

Obesity paradox was observed in both primary and secondary CV prevention patients. A large cohort study should be conducted to definitively determine the clinical significance of obesity paradox, its correlation with the primary and secondary prevention. Potential treatments such as lifestyle modification, ectopic fat reduction, and medications should be investigated.



Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 7986
  • [From(publication date):
    specialissue-2016 - Jan 24, 2018]
  • Breakdown by view type
  • HTML page views : 7926
  • PDF downloads : 60

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version